Life Sciences Directory

Induced pluripotent stem cell (iPSC) derived cell models offer an extraordinary opportunity to study human disease. We have developed a functional genomics screening platform to query biology within the context of these physiologically relevant cell types. We perturb genes at large scale utilising CRISPR knockout, CRISPR activation and CRISPR interference technologies. Our innovative approach is applicable across a wide range of biological questions and disease areas, including target ID.

bit media e-solutions GmbH was founded 2020 and is part of the eee group in Austrai (Graz). bit media is a software company which support the digital transformation and create modern digital products and solutions in the fields of education, security, health and government administration. All products and services are based on continuous innovation, standardization and the use of the latest technologies to maximize the value for the customers.

Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry. The company resides in Graz, Austria. BIT Pharma develops and commercializes technologies for site-specific drug delivery to the central nervous system (CNS), in particular the brain, exploiting tailored drug delivery systems.

Our vision is making healthcare more accessible and providing decentralised testing of biomarkers. Our smart system combines laboratory technology with personalized analysis. Several markers can be measured from as little as a drop of blood from the fingertip in real time. After a test flow of approximately 10 min, the user obtains not just the medical value of the marker of interest but also a tailored report, based on answers given in a questionnaire.

Bloomblisser is a company builder, accelerator, and matchmaking platform specializing in DigitalHealth and MedTech. We transform technology-driven healthcare concepts into successful businesses, focusing on Europe and the DACH region. Our services include market access strategies, regulatory affairs, MDR classification, CE marking, reimbursement paths, and IP protection. Our I2A.at accelerator fast-tracks non-EU companies seeking European market entry.

BlueSky Immunotherapies, ein führendes Biotechnologieunternehmen in der klinischen Entwicklung, hat eine bahnbrechende virale Vektorplattform gegen Krebs entwickelt. Die Plattform namens delNS wurde entwickelt, um sowohl Interferon als auch Tumorantigene gleichzeitig zu produzieren. Dieser innovative Ansatz ist entscheidend, um die Immunabwehrmechanismen von Tumoren zu überwinden und sie effektiv zu bekämpfen.

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.